The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study

  28 September 2019

In this prospective study on critically ill with bloodstream infections, FA-BCID testing led to a substantial 10h02 time-reduction to administration of optimal antimicrobial treatment. This beneficial outcome was certainly a combined impact of the FA-BCID test (bioMerieux) and its around-the-clock realization covering time frames in which culture testing on positive blood bottles was limited or not realized. Thus 80% of the FA-BCID tests enabling a treatment switch occurred outside business hours and 54.3% overnight. This real-time approach has its usefulness for 24h/24 monitored critically ill but could lack clinical responsiveness overnight in other non-critical hospital units.

Source: PLOS One
Authors: Alexia Verroken ,Noémie Despas, Hector Rodriguez-Villalobos,Pierre-François Laterre
Healthy Patients  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market (max 5)
  • Global reach for funding / co-development / licensing
  • No costs (until year end 2019)

Festive Launch Database 19 Nov Symposium Dinner ‘Emerging Antimicrobials and Diagnostics in AMR 2019
Click to join the Symposium Dinner (to join the Symposium separate registration obligatory)

Display your technology >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!